Our challenge is defining the regulatory framework in which we are classed, so in the end, patients can receive our therapies
In Conversation
We exported products from Spain, and we had a clear policy not to make any big investments - we would invest according to our needs, carefully…
[Working in rare diseases] the impact on patients is a lot more rewarding as you are really making the difference between them living or not. Our…
We are the first Spanish company to offer global services including central imaging capabilities and CRO operations at a national and also international level
We want to facilitate the collaboration of the public and private sector, with the objective of building synergies and growing the region’s capacity and competitiveness, not…
Here in Spain, we are given the freedom to build our own culture and company within the group; a very attractive proposition for myself and something…
One of our challenges is changing our mentality. People don’t acknowledge how good the Spanish market is, the great changes introduced by the new regulations, our…
Our ecosystem has moved very quickly in the last ten to 15 years. We have to be smart and strategic about how we handle the funds…
Nowadays, our scientific production has a heavier weight than our economy internationally. What we need is that scientific power to drive economic growth
Although it has been a complicated year because of all the changes in the government, we have managed to achieve good results
Spain is at a point of disruption in which the healthcare system is facing big challenges; the solution to which has to be technology
Along with the EMA and the entire network, we are identifying innovation from the very early stages
